Unknown PHASE2 INTERVENTIONAL NCT00010062

Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer

Study Of Post-Operative Concomitant Radio-Chemotherapy With A Continuous Infusion Of Flourouracil For Adjuvant Treatment Of Resected Pancreatic Cancer

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group

Conditions Pancreatic Cancer

Interventions fluorouracil radiation therapy

Updated 7 times since 2017 Last updated: Feb 6, 2009 Started: Oct 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Pancreatic Cancer and is currently ongoing. GERCOR - Multidisciplinary Oncology Cooperative Group leads this study, which shows 7 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE2
Jan 2017 — Feb 2018 [monthly]

Unknown Status PHASE2

First recorded

Oct 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GERCOR - Multidisciplinary Oncology Cooperative Group

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Annemasse, France , Bagnolet, France , Bordeaux, France , Caen, France , Cagne-sur-Mer, France , Cagnes-sur-Mer, France , Chartres, France , Clichy, France , Colombes, France , Dijon, France and 17 more locations